The safe and effective use of a stand-alone intranasally administered TLR4 agonist and natural exposure to allergens in individuals who are poly-sensitized to multiple seasonal allergens could change the landscape on AIT options available for allergic rhinitis and other atopic diseases. Here, TLR4 is linked to allergic rhinitis.